皮特生物科技初创公司完成A轮融资

Globin Solutions, Inc., a biotechnology startup formed in 2017 by School of Medicine faculty members Mark T. Gladwin, Jack D. Myers, Jason J. Rose and Jesus Tejero Bravo to develop a rapidly acting antidote to carbon monoxide (CO) poisoning, in April completed a Series A funding round of more than $5 million. 在UPMC商业化部门UPMC Enterprises的参与下，中国北京图斯科技服务集团牵头进行了此次谈判。

该基金将支持进一步开发先导化合物，重组神经红蛋白。珠蛋白溶液是大学拥有的知识产权的独家授权方。